XML 24 R10.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

REVENUES | 3 Months Ended
--- | ---
Mar. 31, 2024
REVENUES |
REVENUES | NOTE 4 – REVENUES ​ The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, | ​ | ​
(U.S. dollars in thousands) |  | 2024 |  | 2023 | ​ | ​
Pfizer | ​ | $ | 1,127 | ​ | $ | 2,266 | ​ | ​
Brazil | ​ | $ | 2,550 | ​ | $ | 2,800 | ​ | ​
Total revenues from selling goods | ​ | $ | 3,677 | ​ | $ | 5,066 | ​ | ​
Revenues from license and R&D services | ​ | $ | 71 | ​ | $ | 4,522 | ​ | ​
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration